Ventilator-associated pneumonia in adults: a narrative review
Hôpital Nord · Centre d'Études et de Recherches sur les Qualifications · +7 more institutions
Abstract
Ventilator-associated pneumonia (VAP) is one of the most frequent ICU-acquired infections. Reported incidences vary widely from 5 to 40% depending on the setting and diagnostic criteria. VAP is associated with prolonged duration of mechanical ventilation and ICU stay. The estimated attributable mortality of VAP is around 10%, with higher mortality rates in surgical ICU patients and in patients with mid-range severity scores at admission. Microbiological confirmation of infection is strongly encouraged. Which sampling method to use is still a matter of controversy. Emerging microbiological tools will likely modify our routine approach to diagnosing and treating VAP in the next future. Prevention of VAP is based…
Citation impact
- FWCI
- 61.44
- Percentile
- 100%
- References
- 168
Authors
3- LPLaurent PapazianCorresponding
Hôpital Nord, Centre d'Études et de Recherches sur les Qualifications
- MKMichael Klompas
Brigham and Women's Hospital, Harvard University, Harvard Pilgrim Health Care
- CLCharles‐Édouard Luyt
Inserm, Sorbonne Université, Assistance Publique – Hôpitaux de Paris, Fondation pour l’innovation en Cadiométabolisme et Nutrition
Topics & keywords
- Medicine
- Ventilator-associated pneumonia
- Pneumonia
- Intensive care medicine
- Mechanical ventilation
- Anesthesiology
- Antibiotics
- Randomized controlled trial
- Good health and well-being